1mg 1ml
Internal Medicine
I.M.
Elderly, Adult
Liquid
Liquid Injection
Organic Chemicals
Chemical Synthesis
SL12345
SL12345
Available
Bp or USP
Available
Shenglu
10 Ampoulel Per Box, 200 Box Per Carton
1mg 1ml
China
300490
Product Description
Atropine sulfate injection 1mg 1ml
Atropine sulfate injection 1mg/1ml
Composition:
Each 1 ml contains:
Atropine Sulphate USP.........0.6mg
Water for Injection USP......…q.s.
| Product Name: | Atropine sulfate injection 1mg/1ml |
| Strength: | 1mg/1ml |
| Dosage Form: | For I.M/I.V/S.C. Use |
| Packing: | 1mL Ampoule, 10 ampoule per box |
| Route of Administration: | For I.M/I.V/S.C. Use |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier |
| Storage: | Store below 25°C. Protect from Light. Do not freeze. |
| Therapeutic use: | Cholinergic, Toxicity Antidotes |
| Indication: | Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life-threatening muscarinic effects, e.g., as an antisialagogue, an anti-vagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning, and to treat brady systolic cardiac arrest. |
| Storage: | Store below 25°C, Protected from light. |
WHY Choose Shandong Shenglu Pharmaceutical ?
Shandong Shenglu Pharmaceutical Co., LTD., located at the intersection of Sihe Road North and 327 National Road North, Surabaya County, formerly known as Shandong Sishui Pharmaceutical Factory, was founded in 1987, is a comprehensive pharmaceutical preparation manufacturer approved by Shandong Provincial Health Department Luwei Medicine Word (88) No. 34.
At present, the company has total assets of 267 million yuan and covers an area of 120,000 square meters. The existing fixed staff of more than 220 people, including production, quality inspection, research and development, equipment and other professional and technical personnel 130 people, at the same time has a professional marketing team of more than 30 people. The company's main product dosage forms are small capacity injection, tablet, hard capsule, powder injection (export), by the national registration approval number of 59. It has the annual production capacity of 1 billion small-volume injections, 1 billion tablets, 500 million capsules and 100 million powder-injection.
